Forian Inc. (NASDAQ:FORA – Get Free Report) saw a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 179,000 shares, a growth of 8.0% from the March 31st total of 165,700 shares. Based on an average daily trading volume, of 27,300 shares, the days-to-cover ratio is presently 6.6 days. Currently, 1.2% of the company’s shares are short sold.
Institutional Inflows and Outflows
Institutional investors have recently modified their holdings of the stock. Raymond James Financial Services Advisors Inc. boosted its position in shares of Forian by 11.4% during the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 40,000 shares of the company’s stock worth $89,000 after purchasing an additional 4,092 shares in the last quarter. Independent Advisor Alliance raised its holdings in Forian by 21.2% during the third quarter. Independent Advisor Alliance now owns 22,491 shares of the company’s stock worth $50,000 after buying an additional 3,936 shares during the last quarter. Pathstone Family Office LLC bought a new position in shares of Forian in the third quarter valued at $39,000. Aufman Associates Inc bought a new stake in shares of Forian during the third quarter worth about $117,000. Finally, Oracle Investment Management Inc. lifted its position in Forian by 0.3% in the 3rd quarter. Oracle Investment Management Inc. now owns 1,368,067 shares of the company’s stock valued at $3,051,000 after acquiring an additional 3,738 shares in the last quarter. Institutional investors and hedge funds own 19.25% of the company’s stock.
Forian Stock Performance
Shares of NASDAQ:FORA traded down $0.06 during trading on Tuesday, reaching $2.60. The stock had a trading volume of 8,575 shares, compared to its average volume of 25,761. Forian has a 52 week low of $1.85 and a 52 week high of $4.15. The firm’s fifty day moving average is $2.97 and its 200 day moving average is $2.75. The stock has a market cap of $80.94 million, a price-to-earnings ratio of 7.88 and a beta of 1.03.
Wall Street Analyst Weigh In
Separately, Roth Mkm reaffirmed a “buy” rating and set a $5.00 price target on shares of Forian in a research note on Thursday, April 4th.
View Our Latest Stock Report on FORA
Forian Company Profile
Forian Inc provides software and information solutions, proprietary data driven insights, and predictive analytics to optimize and measure the operational, clinical, and financial performance of its life science and healthcare customers. It operates through three segments: Information & Software, Services, and Other.
See Also
- Five stocks we like better than Forian
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Insider Trading – What You Need to Know
- Hilton Demonstrates Asset Light is Right for Investors
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Forian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forian and related companies with MarketBeat.com's FREE daily email newsletter.